Classification by type isolates four centrifuge architectures that collectively underpin the market’s product mix. Benchtop models, accounting for roughly 45 % of units sold, dominate low‑to‑medium volume settings due to their modest footprint and moderate speed ranges (up to 10,000 rpm). Floor‑standing systems capture about 30 % of the market, offering higher capacity, advanced rotor configurations, and integrated refrigeration for large‑scale processing in central labs. Portable centrifuges, representing 15 % of sales, address field‑based diagnostics and mobile clinics where power constraints and mobility are critical; these devices typically operate below 5,000 rpm and rely on battery packs. Finally, high‑speed refrigerated units comprise the remaining 10 %, serving specialized applications such as plasma protein isolation that demand precise temperature control and speeds exceeding 15,000 rpm. The relative share of each type reflects institutional procurement preferences, workflow intensity, and cost considerations, thereby influencing the aggregate market size through differentiated pricing and adoption rates. Future shifts toward point‑of‑care testing and personalized medicine are likely to increase demand for compact and high‑speed models, modestly reshaping the type distribution.
